Chinanews.com, Beijing, April 23 (Reporter Sun Zifa) The internationally renowned academic journal "Nature" recently published a health research paper that analyzed the long-term impact of new coronary pneumonia (COVID-19) and pointed out that the condition of new coronary pneumonia was severe when it first appeared. It is related to the increased risk of long-term complications and the increased use of medical care resources.
This study detailed the symptoms of more than 87,000 people in the United States after recovering from the acute phase of new coronary pneumonia for up to 6 months, and may help the development of nursing strategies and health system planning.
The paper stated that the industry has basically grasped the characteristics of the acute symptoms of new coronary pneumonia, but has little knowledge of the long-term complications after the new coronavirus (SARS-CoV-2) infection.
In this study, Ziyad Al-Aly of the Veterans Health Care System in Missouri, the corresponding author of the paper, and colleagues used data from the U.S. Department of Veterans Affairs Medical Care Database to analyze 73,435 Diagnosis, medication and test results of up to 6 months after recovery from the acute phase of the new coronary pneumonia for 13 unhospitalized patients and 13,654 hospitalized patients.
By comparing the outcomes of patients with new coronary pneumonia who were not hospitalized, hospitalized, and admitted to the intensive care unit after hospitalization, they found an increasing risk gradient: the most severely ill people are also at higher risk of other pneumonia-related health problems in the later stages.
The study also found that after the first 30 days of onset, all patients with new coronary pneumonia have an increased risk of death, and it is easier to seek medical treatment for other problems than the nearly 5 million people in the Veterans Health Management Center who have not contracted new coronary pneumonia or were hospitalized. Rescue.
These problems include respiratory diseases, neurological diseases, mental health problems, metabolic and cardiovascular diseases, fatigue, fatigue, musculoskeletal pain and anemia.
Patients who experience long-term symptoms will also experience an increase in the use of various drugs, including antidepressants, anti-anxiety drugs, and pain relief drugs.
The authors of the paper also pointed out that although their research has clarified the symptoms of patients after being infected with new coronary pneumonia, they cannot determine whether these symptoms are direct or indirect effects of new coronary pneumonia.
(Finish)